Please provide your email address to receive an email when new articles are posted on . ATLANTA — Treatment with repeat doses of rituximab is superior to daily azathioprine for preventing relapse ...
A recent report by Buckley et al analyzed a previous study to determine the differences in second and third relapse rates in patients receiving long-acting injectable risperidone versus an oral second ...
John M. Kane, MD: When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. Someone who ...
For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...
Relapses can have devastating consequences for people with mental disorders such as schizophrenia, bipolar disorder, depression, or an anxiety disorder. After every relapse, it may become increasingly ...
Avelumab demonstrated a 53% response rate in chemo-resistant gestational trophoblastic tumors, with no relapse after 29 months of follow-up. The study suggests avelumab as a potential alternative to ...
Please provide your email address to receive an email when new articles are posted on . Clozapine and second-generation long-acting formulations of certain antipsychotics decreased risk for ...
The authors reviewed the literature to identify high-quality studies (observational and controlled) of ANCA-associated vasculitis that included a predetermined target dose of steroids at the end of ...
Is artificial intelligence the key to preventing relapse of severe mental illness? New AI software developed by researchers at Flinders University shows promise for enabling timely support ahead of ...
Medical University of South Carolina scientists report in Neuron that they have uncovered a way to restore an opioid-weakened brain pathway in a preclinical model. With funding from the National ...
FILE PHOTO: Bottles of prescription painkillers Oxycodone Hydrochloride, 30mg, sit on a counter at a local pharmacy in Provo, Utah, April 25, 2017. REUTERS/George Frey/File Photo A good night’s sleep ...
A 2015 study comparing schizophrenia patients who received oral or injectable antipsychotic medications found no difference in relapse rates between the groups. Now, a follow-up study published August ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results